Close Asset Management LTD Editas Medicine, Inc. Transaction History

Close Asset Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$9.99 - $21.35 $7,692 - $16,439	-770 Reduced 98.72%	10 $0
Q3 2021 Nov 04, 2021	SELL	$39.27 - $72.94 $18,574 - $34,500	-473 Reduced 37.75%	780 $32,000
Q2 2021 Jul 27, 2021	BUY	$31.29 - $56.64 $39,112 - $70,800	1,250 Added 41666.67%	1,253 $71,000
Q1 2021 May 07, 2021	BUY	$39.71 - $90.58 $119 - $271	3 New	3 $0

244

56.8M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Close Asset Management LTD with notifications on news.